A NONCYTOTOXIC SUPPRESSOR OF IMMUNOGLOBULIN-SYNTHESIS AND SECRETION BY B-CELLS OF NORMAL HUMANS AND PATIENTS WITH RHEUMATOID-ARTHRITIS AND SYSTEMIC LUPUS-ERYTHEMATOSUS

被引:0
|
作者
RICHTER, M
KAPLAN, H
KRAAG, G
TALOR, E
JODOUIN, CA
机构
[1] Department of Pathology and Microbiology/Immunology, Faculty of Medicine, Ottawa, ON
[2] Department of Chemistry, University of Ottawa, Ottawa, ON
[3] The Immunology Laboratory, Ottawa, ON
[4] The Division of Rheumatology, Department of Medicine, Ottawa Civic Hospital, Ottawa, ON
[5] Department of Immunology and Infectious Diseases, School of Hygiene, The Johns Hopkins University, Baltimore, MD, 21205
关键词
SUPPRESSION OF IMMUNOGLOBULIN SYNTHESIS; SUPPRESSION OF AUTOANTIBODY SYNTHESIS; HUMAN; NONTOXIC SUPPRESSOR FACTOR;
D O I
10.3109/08916939109035141
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A factor secrected by thymocytes of immunized rabbits totally suppressed both the initiation of, and ongoing synthesis and secretion of, lectin (PWM)-induced synthesis of IgM and IgG immunoglobulins by the circulating B lymphocytes of normal humans, and of twenty consecutive patients with rheumatoid arthritis and twelve consecutive patients with systemic lupus erythematosus. The suppressor factor, referred to as human Ig synthesis/secretion suppressor factor or HISSF, is not HLA restricted in its activity and is not cytotoxic to the circulating human mononuclear cells (B cells, T cells. Null cells and monocytes). It was demonstrated that T cells precultured with HISSF were transformed into suppressor cells which, when added to fresh cultures of autologous B cells, suppressed the synthesis and secretion of IgM and IgG. On the basis of its suppressive and non-cytotoxic properties in vitro, HISSF may be an effective immunosuppressant in the treatment of patients with autoimmune diseases. © 1991 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:107 / 117
页数:11
相关论文
共 50 条
  • [1] SPONTANEOUSLY ENHANCED INVITRO IMMUNOGLOBULIN-SYNTHESIS BY B-CELLS IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    OKUDAIRA, K
    TANIMOTO, K
    NAKAMURA, T
    HORIUCHI, Y
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1980, 16 (03): : 267 - 278
  • [2] SYSTEMIC LUPUS-ERYTHEMATOSUS AND RHEUMATOID-ARTHRITIS
    HUGHES, GRV
    JOURNAL OF CLINICAL PATHOLOGY, 1976, 29 (01) : 83 - 83
  • [3] IMMUNOGLOBULIN AND COMPLEMENT DEPOSITION IN SKIN OF RHEUMATOID-ARTHRITIS AND SYSTEMIC LUPUS-ERYTHEMATOSUS PATIENTS
    SCHROETER, AL
    CONN, DL
    JORDON, RE
    ANNALS OF THE RHEUMATIC DISEASES, 1976, 35 (04) : 321 - 326
  • [4] IMMUNOGLOBULIN-SYNTHESIS BY PERIPHERAL-BLOOD CELLS IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    JASIN, HE
    ZIFF, M
    ARTHRITIS AND RHEUMATISM, 1975, 18 (03): : 219 - 228
  • [5] RHEUMATOID-ARTHRITIS FOLLOWED BY SYSTEMIC LUPUS-ERYTHEMATOSUS
    ANSELL, BM
    PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1975, 68 (09): : 596 - 597
  • [6] DIAGNOSIS OF RHEUMATOID-ARTHRITIS AND SYSTEMIC LUPUS-ERYTHEMATOSUS
    SOLOMON, SD
    ARTHRITIS AND RHEUMATISM, 1979, 22 (04): : 430 - 430
  • [7] THE COEXISTENCE OF RHEUMATOID-ARTHRITIS AND SYSTEMIC LUPUS-ERYTHEMATOSUS
    VENEGONI, C
    CHEVALLARD, M
    MELE, G
    BANFI, G
    CARRABBA, M
    CLINICAL RHEUMATOLOGY, 1987, 6 (03) : 439 - 445
  • [8] RHEUMATOID-ARTHRITIS AND SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)
    GUMPEL, JM
    PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1973, 66 (09): : 910 - 910
  • [9] SUPPRESSION OF IMMUNOGLOBULIN-SYNTHESIS BY MONOCYTES IN HEALTH AND IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    LAUGHTER, AH
    LIDSKY, MD
    TWOMEY, JJ
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1979, 14 (04): : 435 - 440
  • [10] IMMUNOGLOBULIN-PRODUCING CELLS IN LABIAL SALIVARY-GLANDS OF PATIENTS WITH RHEUMATOID-ARTHRITIS AND SYSTEMIC LUPUS-ERYTHEMATOSUS
    MATTHEWS, JB
    POTTS, AJC
    HAMBURGER, J
    STRUTHERS, G
    SCOTT, DGI
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1986, 15 (10) : 520 - 523